A unique resource providing researchers from Texas A&M and the Texas Medical Center with access to state-of-the-art tools to support the discovery of new drugs and new treatments for some of the most devastating diseases of our time. The Screening Center has assembled a world-class team of research scientists, state-of-the-art laboratory robotics and imaging instruments and a remarkable collection of more than 80,000 drugs and chemical compounds. This program is a leader in the growing field of combinatorial therapeutics and is particularlyinterested in the development of informatics-based approaches to the discovery of novel combinatorial therapies for the treatment of cancer.
Our goal is to “to promote the development of new and improved combinatorial therapies for the treatment of cancer.” It is our hypothesis, that providing Texas’ cancer researchers with access to collections of established (FDA approved) drugs, sophisticated high-throughput technologies and experts in bioinformatics and drug discovery research, the Combinatorial Drug Discovery Program can promote the development of novel combinatorial drug regimens for the treatment of cancer.
• Tecan Evo Freedom 200 - three arm robotic workstation (96/384/1536 microwell capable), 8 channel liquid Handling Arm
• Beckman FX - dual arm robotic workstation (96/384-microwell capable),
Span-8 Liquid handling arm
• Tecan Evo Freedom 100 - single arm robotic workstation (96/384 microwell capable), 4 channel liquid Handling Arm
• Beckman NXp - single arm robotic workstation (96/384-microwell capable), multi-channel arm
Clifford Stephan, PhD
Research Associate Professor
Center for Translational Cancer Research